insights_auto
ALMKT の下落理由: 3.57%?
さらに詳しくchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€0.089
arrow_downward
-3.57%(-0.0033) 1 日
11月18日, 11:20:12 GMT+1 · EUR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoALMKT の上位の分析情報を生成しています...
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1764.94万
平均出来高
48.14万
取引量
2.28万
株価収益率
0.76
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1764.94万
平均出来高
48.14万
取引量
2.28万
株価収益率
0.76
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
ニュース記事
情報源: ウェブソース、ニュース パートナー
The Motley Fool
·
20 分前
Vanguard S&P 500 ETF vs. Schwab U.S. Dividend ETF: How Much You’d Need to Collect $1,000 a Month From Each.
Benzinga
·
43 分前
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead of FOMC Minutes— NVDA, AAOI, PANW in Focus
MarketWatch
·
1 時間前
The S&P 500 just broke a crucial support level. Here’s what history shows may happen now.
www.tokenpost.com
·
1 時間前
Nasdaq Gains 0.91% as S&P 500 Futures and Dow Also Advance
プロフィール
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA について